Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Aditya Birla Capital consolidated net profit rises 30.60% in the March 2026 quarter
Sales rise 10.19% to Rs 13459.25 crore
Aditya Birla Capital Q4 Results: Profit rises 31% YoY to ₹1,129 crore
Aditya Birla Capital Q4 Results: Aditya Birla Capital reported a 30.6% increase in Q4 consolidated net profit to ₹1,129.16 crore, with total income rising to ₹13,475.74 crore. The lending portfolio expanded 32%, while the direct-to-consumer platform onboarded 1.1 crore customers by March 2026.
Q4 Results LIVE Updates: DMart shares down 4%, ideaForge Technologies up 16%; Ambuja report today
Q4 Results LIVE Updates: Amubja Cements, Manappuram Finance, Godrej Properties, Aditya Birla Capital, Tata Technologies, KEI Industries, Jindal Stainless, BHEL, Aarti Industries, Sobha, Quess Corp, Tata Chemicals, Wockhardt, are among the companies reporting their earnings today. Also watch for earnings reactions from Avenue Supermarts, Kotak Mahindra Bank, CDSL, NSDL, Zen Technologies, Mazagon Dock and others. Watch this space for all the LIVE earnings reactions.
Invesco India Gold ETF - Upstox
Invesco India Gold ETFUpstox
Gold loans surge five time in two years
Bank loans against jewellery rose nearly fivefold to ₹4.6 lakh crore at the end of March from ₹93,301 crore two years ago, registering a 123% year-on-year growth—the fastest across sectors, according to data from the Reserve Bank of India.
IIFL Finance Q4 profit nearly triples, powered by booming gold loans and better asset quality
IIFL Finance Q4 net profit jumps to ₹586.8 crore, revenue and gold loan AUM surge, asset quality improves, management eyes sustainable growth in FY27. Shares of IIFL Finance ended higher on Wednesday, April 29, by 2.5% at ₹449.00 on the NSE.
Sun Pharma a trading play on dips, banks may face difficult June quarter: Dharmesh Kant
Dharmesh Kant, Head of Research at Chola Securities, said Sun Pharma’s all-cash acquisition of Organon could improve return ratios and support valuations, but may bring overall revenue growth down to single digits. He sees a trading opportunity in Sun Pharma on price dips. On banking, he said Q1 could be difficult as provisioning picks up, which may weigh on profitability even as asset quality and margins remain stable. Disclaimer: The views and tips expressed by investment experts on CNBCTV18.com are their own, not of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.
Q4 Results LIVE Updates: UTI AMC profit drops 73%; IEX operating profit up 23%
Q4 Results LIVE Updates: Infosys, LTIMindtree, IEX, Union Bank of India, Aditya Birla Sun Life AMC, Adani Energy Solutions, CIE India, Bluestone Jewellery, Mahindra Logistics, Tata Capital, Sterling & Wilson Renewables, Tata Teleservices (Maharashtra), and UTI AMC are among the important earnings to track today. The street will react to results reported by Trent, BCCL, and other companies as well. Watch this space for all the LIVE updates.
Aditya Birla Sun Life AMC Q4 results: Cons PAT drops 18% YoY; co announces Rs 25.50/share dividend, stock surges 6%
Aditya Birla Sun Life AMC reported an 18% year-on-year decline in Q4 profit, even as revenue saw modest growth. The company announced a Rs 25.50 dividend per share. Despite weak earnings and higher expenses, the stock gained nearly 6%, supported by investor sentiment and stable AUM performance.
Exclusive | Pirojsha Godrej bets big on financial services; plans gold loan foray in FY27
Godrej Industries sees financial services as its fastest-growing vertical, with plans to scale AUM to ₹1 lakh crore, while real estate and consumer businesses continue to anchor growth, Chairman-designate Pirojsha Godrej said.
Aditya Birla Sun Life AMC Q4 profit falls 18%; revenue rises nearly 7%
Aditya Birla Sun Life AMC Q4 net profit fell 18% to ₹187 crore from ₹228 crore, while revenue rose 6.8% to ₹458 crore from ₹429 crore.
SBI Life shares slip after Q4 results but Street sees margin recovery ahead
SBI Life has guided for 14% growth in FY27, with margins expected in the 27% to 28% range.